Personal information

Other IDs

Scopus Author ID: 57204636135

Countries

Iran

Activities

Collapse all

Education and qualifications (1)

University of Tabriz: Tabriz, East Azerbaijan, IR

2012-09 to 2019-08 | Doctor of veterinary medicine (Veterinary medicine)
Education
Source: Self-asserted source
Hamed Ezzati

Works (5)

mir-451a-5p Modulates Breast Cancer Cell Apoptosis, Migration, and Chemosensitivity to Carboplatin through the PTEN Pathway

Pharmaceutical Sciences
2023-07-01 | Journal article
DOI: 10.34172/PS.2022.28
Contributors: Monireh Khordadmehr; Hamed Ezzati; Amirali Shahbazfar; Farinaz Jigari-Asl; Behzad Baradaran; Elham Baghbani; Saeed Noorolyai
Source: check_circle
Crossref

Targeting ROCK signaling in health, malignant and non-malignant diseases

Immunology Letters
2020-03 | Journal article
DOI: 10.1016/j.imlet.2019.12.012
Contributors: Roya Shahbazi; Behzad Baradaran; Monireh Khordadmehr; Sahar Safaei; Amir Baghbanzadeh; Farinaz Jigari; Hamed Ezzati
Source: check_circle
Crossref

A comprehensive review on miR-451: A promising cancer biomarker with therapeutic potential

Journal of cellular physiology
2019 | Journal article
DOI: 10.1002/jcp.28888
Source: Self-asserted source
Hamed Ezzati

Key microRNAs in the biology of breast cancer; emerging evidence in the last decade

Journal of Cellular Physiology
2019 | Journal article
DOI: 10.1002/jcp.27716
EID:

2-s2.0-85056449302
Contributors: Khordadmehr, M.; Shahbazi, R.; Ezzati, H.; Jigari-Asl, F.; Sadreddini, S.; Baradaran, B.
Source: Self-asserted source
Hamed Ezzati via Scopus - Elsevier
grade
Preferred source (of 2)‎

Anti-tumor activity of propofol: A focus on microRNAs

Current Cancer Drug Targets
2019-10-23 | Journal article
DOI: 10.2174/1568009619666191023100046
Part of ISSN: 1568-0096
Source: Self-asserted source
Hamed Ezzati
How many people are using ORCID?